U
Molecule Holdings Inc. EVRRF
$0.00 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

07/31/2023 04/30/2023 01/31/2023 10/31/2022 07/31/2022
Net Income 15.38% 18.67% 21.62% -4.63% 30.25%
Total Depreciation and Amortization -4.92% -6.03% -5.47% 11.84% 55.07%
Total Amortization of Deferred Charges -109.78% -40.18% -66.21% -66.21% -88.40%
Total Other Non-Cash Items 61.52% -16.45% -70.74% -44.77% -70.34%
Change in Net Operating Assets 877.11% 6,720.34% 275.03% 240.63% 128.67%
Cash from Operations 96.03% 85.14% 86.01% 60.86% -2.93%
Capital Expenditure 100.00% 107.55% 142.35% 56.33% 93.64%
Sale of Property, Plant, and Equipment -- -- -- -- 53.28%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 3,029.17% 26.06% -99.85% -98.06% -99.07%
Cash from Investing 477.69% -19.05% -76.39% -117.32% -79.53%
Total Debt Issued -66.05% -68.33% -75.25% -75.25% -52.89%
Total Debt Repaid -820.41% -394.32% -400.32% -406.80% -3.61%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 87.89% 7.34% -6.75% -34.67% 25.76%
Cash from Financing -107.34% -91.89% -96.50% -98.63% -59.62%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 93.12% -200.77% -571.52% -428.46% -277.79%